image
Gilead Sciences, Inc. GILD
Healthcare - Drug Manufacturers - General - NASDAQ - US
Watchlist
$ 116.6
2 %
$ 145 B
Market Cap
25.29
P/E
CASH FLOW STATEMENT
10.8 B OPERATING CASH FLOW
35.25%
Growth Rates
1Year 35.25%
3Years -1.66%
5Years 3.44%
7Years -1.34%
10Years -1.67%
-3.45 B INVESTING CASH FLOW
-52.27%
Growth Rates
1Year -52.27%
3Years -3.28%
5Years 15.10%
7Years 19.73%
10Years -6.58%
-3.43 B FINANCING CASH FLOW
33.01%
Growth Rates
1Year 33.01%
3Years 27.14%
5Years 14.77%
7Years -10.50%
10Years -1.27%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Gilead Sciences, Inc.
image
Net Income 480 M
Depreciation & Amortization 0
Capital Expenditures 0
Stock-Based Compensation 0
Change in Working Capital 0
Others 10.8 B
Free Cash Flow 10.8 B

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Mar-1995 Mar-1993 Mar-1992 Mar-1991
OPERATING CASH FLOW
Net Income 0 5 613.0 4 566.0 6 201.0 89.0 5 364.0 5 460.0 4 644.0 13 488.0 18 106.0 12 059.0 3 057.3 2 573.6 2 789.1 2 889.7 2 625.6 2 011.2 1 615.3 (1 190.0) 813.9 449.4 (72.0) 72.1 52.3 (43.1) (66.5) (56.1) (28.0) (21.7) (27.4) (25.7) (14.1) (4.5) (4.0)
Depreciation & Amortization 0 2 693.0 2 103.0 2 050.0 1 480.0 1 404.0 1 429.0 1 286.0 1 158.0 1 098.0 1 050.0 344.7 278.2 302.2 265.5 212.9 102.5 51.3 47.3 35.8 24.4 20.9 14.4 14.7 12.0 12.6 2.8 3.0 4.5 3.2 2.8 1.7 1.0 0.8
Deferred Income Tax 0 (962.0) (1 552.0) (116.0) (214.0) (2 098.0) 289.0 (82.0) 67.0 193.0 248.0 186.5 73.2 101.3 12.2 (42.0) (4.1) 133.1 (9.2) (53.2) 151.6 (250.1) 0 (0.2) 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 0 766.0 637.0 635.0 643.0 636.0 845.0 638.0 380.0 382.0 360.0 252.0 208.7 192.4 200.0 180.7 153.4 184.6 133.8 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 10 828.0 2 199.0 5 081.0 2 125.0 7 808.0 4 636.0 1 316.0 304.0 214.0 (609.0) (381.0) (172.8) (116.1) 33.7 146.9 72.6 8.6 17.2 2 461.3 179.4 8.9 387.8 23.1 (124.3) (0.5) 11.4 0.5 100 K 100 K 100 K (0.5) 0 100 K 100 K
Change in Working Capital 0 (2 303.0) (1 763.0) 489.0 (1 638.0) (798.0) (939.0) 5 108.0 1 362.0 1 159.0 (518.0) (562.7) 177.1 220.3 (680.4) 30.2 (66.9) (236.1) (225.1) (260.8) (122.9) (102.1) (35.3) (30.8) (6.6) (20.1) 6.1 5.2 0.8 1.1 1.0 3.5 100 K 0.9
Cash From Operations 10 828.0 8 006.0 9 072.0 11 384.0 8 168.0 9 144.0 8 400.0 11 898.0 16 669.0 20 329.0 12 818.0 3 105.0 3 194.7 3 639.0 2 833.9 3 080.1 2 204.7 1 765.4 1 218.1 715.1 511.4 234.6 74.4 (88.1) (38.2) (62.6) (46.7) (19.9) (16.5) (23.0) (22.4) (8.9) (3.7) (2.4)
INVESTING CASH FLOW
Capital Expenditures 0 (585.0) (728.0) (579.0) (650.0) (825.0) (924.0) (590.0) (748.0) (747.0) (557.0) (190.8) (397.0) (131.9) (61.9) (230.1) (115.0) (78.6) (105.2) (48.0) (51.4) (38.6) (17.6) (26.3) (15.6) (12.5) (2.5) (3.9) (3.7) (0.6) (3.2) (4.4) (0.5) (0.3)
Other Items (3 449.0) (1 680.0) (1 738.0) (2 552.0) (13 965.0) (6 992.0) 15 279.0 (15 479.0) (11 237.0) (11 728.0) (1 266.0) (63.6) (11 449.0) 3 721.7 (1 875.9) (1 985.8) (63.8) (1 223.8) (1 634.1) (644.0) (439.5) (688.7) 63.4 47.1 (68.6) (3.8) 42.5 (126.0) (35.8) (69.3) 35.3 (119.7) (17.5) 0
Cash From Investing Activities (3 449.0) (2 265.0) (2 466.0) (3 131.0) (14 615.0) (7 817.0) 14 355.0 (16 069.0) (11 985.0) (12 475.0) (1 823.0) (254.4) (11 846.1) 3 589.8 (1 937.8) (2 215.9) (178.8) (1 302.5) (1 739.3) (691.9) (490.8) (727.3) 45.8 20.8 (84.2) (16.3) 40.0 (129.9) (39.5) (69.9) 32.1 (124.1) (18.0) (0.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 (1 000.0) (1 396.0) (546.0) (1 583.0) (1 749.0) (2 900.0) (954.0) (11 001.0) (10 002.0) (5 349.0) (582.4) (667.0) (2 383.1) (4 022.6) (998.5) (1 969.6) (487.5) (544.9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 (270.0) (1 500.0) (4 750.0) 5 684.0 (2 750.0) (6 250.0) 7 174.0 4 268.0 9 689.0 5 670.0 (2 705.2) 519.0 4 009.2 2 094.1 (311.1) (4.3) (99.5) 1 074.7 298.6 (0.1) (1.7) 335.2 (2.8) 238.6 (5.3) (7.2) 57.4 0.2 (2.1) 4.2 0 (0.4) 100 K
Dividends Paid 0 (3 809.0) (3 709.0) (3 605.0) (3 449.0) (3 222.0) (2 971.0) (2 731.0) (2 455.0) (1 874.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (3 433.0) (278.0) (173.0) (145.0) (138.0) (122.0) (486.0) (330.0) (745.0) (3 095.0) (3 677.0) 430.2 245.3 (74.2) 368.6 35.4 191.9 76.3 (283.9) 0 0 0 0 0 0 0 100 K 0 0 0 (4.1) 0 0 0
Cash From Financing Activities (3 433.0) (5 125.0) (6 469.0) (8 877.0) 770.0 (7 634.0) (12 318.0) 3 393.0 (9 347.0) (4 963.0) (3 025.0) (2 543.9) 563.3 1 763.6 (1 338.7) (1 051.4) (1 535.8) (267.3) 649.3 441.9 78.7 82.1 386.6 33.5 269.0 24.0 7.2 49.8 160.6 90.0 1.2 47.2 99.3 7.7
CHANGE IN CASH
Net Change In Cash 3 906.0 673.0 74.0 (659.0) (5 634.0) (6 309.0) 10 352.0 (641.0) (4 622.0) 2 824.0 7 914.0 309.1 (8 080.1) 8 975.9 (365.1) (186.3) 491.2 152.1 108.1 427.0 86.2 (422.2) 493.4 (35.0) 150.3 (54.1) 0.5 (100.0) 104.6 (2.9) 10.9 (85.8) 77.6 5.0
FREE CASH FLOW
Free Cash Flow 10 828.0 7 421.0 8 344.0 10 805.0 7 518.0 8 319.0 7 476.0 11 308.0 15 921.0 19 582.0 12 261.0 2 914.2 2 797.7 3 507.1 2 772.0 2 850.0 2 089.7 1 686.8 1 112.9 667.1 460.0 196.0 56.8 (114.5) (53.8) (75.1) (49.2) (23.8) (20.2) (23.6) (25.6) (13.3) (4.2) (2.7)